We advised Ribosepharm
Medeva Plc, London, UK
Medeva plc is a pharma company that was originally focused on vaccines. It implemented strong growth especially through the acquisition of pharmaceutical companies and now has a diversified portfolio of pharma activities.
Sale of Ribosepharm GmbH, Düsseldorf, to Medeva through private German owners. Ribosepharm is a pharma company specialized in cancer drugs.
HSCie and Edward Niggli, Basel, Switzerland, advised on the decision-making process, valuation, due diligence and negotiations.
Transaction value: Not published
Business field: Mergers & Acquisitions